{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:05:56Z","timestamp":1784081156076,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical Research Council","award":["38406_DillonJ_MRC ICASE Studentship-FA"],"award-info":[{"award-number":["38406_DillonJ_MRC ICASE Studentship-FA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Overdose induced by illicit drug use is a significant public health threat in many settings globally. Many such overdoses occur in the context of lone use in private spaces, in the absence of potential first responders. Chest-worn biosensors have the potential to detect respiratory depression which signal overdose and alert first responders, enabling rapid reversal. However, the acceptability of this approach to people who use drugs and other key stakeholders are not known. We aimed to investigate these outcomes in this qualitative sub-study, which is part of a larger trial investigating this intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Semi-structured interviews and focus groups were conducted with participants who completed the study protocol (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200920), partially completed the study protocol (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091) and stakeholder groups (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098) about device acceptability. Verbatim transcripts were analysed using reflexive thematic analysis. Factors influencing device acceptability for PWUD were interpreted using the concepts of the COM-B behaviour model. Discussions around implementation with stakeholder groups utilised Normalisation Process Theory to further appraise the intervention and its integration into existing services.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Experiences with overdose or drug-related deaths (DRD) were identified within qualitative data as motivating factors for device wear. First responder groups stressed the importance of patient choice and device accuracy. The accelerometer sensor was found to be acceptable to people who use drugs (PWUD) and was utilised to monitor respiratory patterns. Stakeholders recognised the potential of these devices to play a part in the management of overdose and identified necessary requirements to ensure successful implementation of the device, such as funding allocation, potential barriers and integration into existing services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The chest-worn biosensor was acceptable to PWUD, driven by personal experiences with overdose risks, and were viewed by stakeholders as a promising tool for overdose management. Successful implementation will require ensuring device accuracy, respecting patient choice, securing funding, and integrating the technology into existing services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trials registration<\/jats:title>\n                    <jats:p>Researchregistry7351<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-026-01452-8","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:59:30Z","timestamp":1779350370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acceptability and usability of a respiratory biosensor for drug overdose detection and first responder notification: a qualitative evaluation of perspectives from people who use drugs and wider stakeholders"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1163-3105","authenticated-orcid":false,"given":"Kristina","family":"Hn\u00edzdilov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4772-2388","authenticated-orcid":false,"given":"Andrew","family":"Radley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3223-6782","authenticated-orcid":false,"given":"Madeleine","family":"Caven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian Paul","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7586-7712","authenticated-orcid":false,"given":"Christopher J.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8268-0490","authenticated-orcid":false,"given":"Osian","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0464-3331","authenticated-orcid":false,"given":"Bruce","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2164-4476","authenticated-orcid":false,"given":"John Francis","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"1452_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","volume":"71","author":"D Ciccarone","year":"2019","unstructured":"Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183\u20138.","journal-title":"Int J Drug Policy"},{"key":"1452_CR2","unstructured":"Tayside drug death review group. Drug deaths in Tayside, Scotland 2020 Annual report. 2021."},{"issue":"11","key":"1452_CR3","first-page":"866","volume":"63","author":"J Ng","year":"2017","unstructured":"Ng J, Sutherland C, Kolber MR. Does evidence support supervised injection sites? Can Fam Physician. 2017;63(11):866.","journal-title":"Can Fam Physician"},{"issue":"23","key":"1452_CR4","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1056\/NEJMc052939","volume":"354","author":"E Wood","year":"2006","unstructured":"Wood E, Tyndall MW, Zhang R, Stoltz J-A, Lai C, Montaner JS, et al. Attendance at supervised injecting facilities and use of detoxification services. N Engl J Med. 2006;354(23):2512\u20134.","journal-title":"N Engl J Med"},{"key":"1452_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108078","volume":"213","author":"N Kerman","year":"2020","unstructured":"Kerman N, Manoni-Millar S, Cormier L, Cahill T, Sylvestre J. \u201cIt\u2019s not just injecting drugs\u201d: supervised consumption sites and the social determinants of health. Drug Alcohol Depend. 2020;213:108078.","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"1452_CR6","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.3390\/ijerph19116575","volume":"19","author":"J Nicholls","year":"2022","unstructured":"Nicholls J, Livingston W, Perkins A, Cairns B, Foster R, Trayner KM, et al. Drug consumption rooms and public health policy: perspectives of scottish strategic decision-makers. Int J Environ Res Public Health. 2022;19(11):6575.","journal-title":"Int J Environ Res Public Health"},{"key":"1452_CR7","doi-asserted-by":"crossref","unstructured":"Christie B. Safe space for injecting drugs is approved in Scotland. 2023.","DOI":"10.1136\/bmj.p2238"},{"key":"1452_CR8","unstructured":"Edinburgh integration joint board. Notice of meeting and agenda. 2025."},{"key":"1452_CR9","doi-asserted-by":"crossref","unstructured":"Mahmud MS, Fang H, Wang H, Carreiro S, Boyer E, editors. Automatic detection of opioid intake using wearable biosensor. 2018 international conference on computing, networking and communications (ICNC); 2018.","DOI":"10.1109\/ICCNC.2018.8390334"},{"issue":"4","key":"1452_CR10","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/dar.13645","volume":"42","author":"B Tas","year":"2023","unstructured":"Tas B, Lawn W, Traykova EV, Evans RA, Murvai B, Walker H, et al. A scoping review of mHealth technologies for opioid overdose prevention, detection and response. Drug Alcohol Rev. 2023;42(4):748\u201364.","journal-title":"Drug Alcohol Rev"},{"issue":"6","key":"1452_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"key":"1452_CR12","unstructured":"Pneumowave Limited. Pneumowave Online 2023 [Available from: https:\/\/pneumowave.com\/."},{"issue":"4","key":"1452_CR13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/2159676X.2019.1628806","volume":"11","author":"V Braun","year":"2019","unstructured":"Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qual Res Sport Exerc Health. 2019;11(4):589\u201397.","journal-title":"Qual Res Sport Exerc Health"},{"issue":"2","key":"1452_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"issue":"1","key":"1452_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1748-5908-6-42","volume":"6","author":"S Michie","year":"2011","unstructured":"Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):42.","journal-title":"Implement Sci"},{"issue":"1","key":"1452_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-5908-4-29","volume":"4","author":"CR May","year":"2009","unstructured":"May CR, Mair F, Finch T, MacFarlane A, Dowrick C, Treweek S, et al. Development of a theory of implementation and integration: normalization process theory. Implement Sci. 2009;4(1):1\u20139.","journal-title":"Implement Sci"},{"issue":"2","key":"1452_CR17","doi-asserted-by":"publisher","first-page":"e187672","DOI":"10.1001\/jamanetworkopen.2018.7672","volume":"2","author":"TM Krummel","year":"2019","unstructured":"Krummel TM. The rise of wearable technology in health care. JAMA Netw Open. 2019;2(2):e187672-e.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1452_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-021-00522-3","volume":"18","author":"K Kanter","year":"2021","unstructured":"Kanter K, Gallagher R, Eweje F, Lee A, Gordon D, Landy S, et al. Willingness to use a wearable device capable of detecting and reversing overdose among people who use opioids in Philadelphia. Harm Reduct J. 2021;18(1):1\u201314.","journal-title":"Harm Reduct J"},{"issue":"4","key":"1452_CR19","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/pubmed\/fdw138","volume":"39","author":"A Radley","year":"2017","unstructured":"Radley A, Melville K, Easton P, Williams B, Dillon JF. \u2018Standing outside the junkie door\u2019\u2014service users\u2019 experiences of using community pharmacies to access treatment for opioid dependency. J Public Health (Oxf). 2017;39(4):846\u201355.","journal-title":"J Public Health (Oxf)"},{"issue":"2","key":"1452_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/09687637.2021.1886253","volume":"29","author":"P Mayock","year":"2022","unstructured":"Mayock P, Butler S. \u201cI\u2019m always hiding and ducking and diving\u201d: the stigma of growing older on methadone. Drugs Educ Prev Policy. 2022;29(2):139\u201349.","journal-title":"Drugs Educ Prev Policy"},{"issue":"4","key":"1452_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/09687637.2022.2070057","volume":"30","author":"J Xavier","year":"2023","unstructured":"Xavier J, Greer A, Crabtree A, Buxton JA. Police officers\u2019 perceptions of their role at overdose events: a qualitative study. Drugs Educ Prev Policy. 2023;30(4):361\u201372.","journal-title":"Drugs Educ Prev Policy"},{"key":"1452_CR22","doi-asserted-by":"crossref","unstructured":"Bucerius SM, Krahn H, Haggerty KD, Berardi L, McNeilly R. Policing the overdose crisis. Kriminologisches J. 2023; 55(3).","DOI":"10.3262\/KJ2303180"},{"issue":"10","key":"1452_CR23","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3109\/10826084.2016.1168447","volume":"51","author":"EE Bonar","year":"2016","unstructured":"Bonar EE, Bohnert AS. Perceived severity of and susceptibility to overdose among injection drug users: relationships with overdose history. Subst Use Misuse. 2016;51(10):1379\u201383.","journal-title":"Subst Use Misuse"},{"issue":"4","key":"1452_CR24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/0033354919857084","volume":"134","author":"S Moallef","year":"2019","unstructured":"Moallef S, Nosova E, Milloy M, DeBeck K, Fairbairn N, Wood E, et al. Knowledge of fentanyl and perceived risk of overdose among persons who use drugs in Vancouver, Canada. Public Health Rep. 2019;134(4):423\u201331.","journal-title":"Public Health Rep"},{"issue":"6","key":"1452_CR25","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/jvh.13269","volume":"27","author":"M Caven","year":"2020","unstructured":"Caven M, Robinson EM, Eriksen AJ, Fletcher EH, Dillon JF. Hepatitis C diagnosis and treatment, impact on engagement and behaviour of people who inject drugs, a service evaluation, the hooked C project. J Viral Hepat. 2020;27(6):576\u201384.","journal-title":"J Viral Hepat"},{"issue":"3","key":"1452_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/add.16031","volume":"118","author":"SR Donaldson","year":"2023","unstructured":"Donaldson SR, Radley A, Dillon JF. Transformation of identity in substance use as a pathway to recovery and the potential of treatment for Hepatitis C: a systematic review. Addiction. 2023;118(3):425\u201337.","journal-title":"Addiction"},{"issue":"1","key":"1452_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/jvh.13009","volume":"26","author":"A Malaguti","year":"2019","unstructured":"Malaguti A, Sani F, Stephens BP, Ahmad F, Dugard P, Dillon JF, et al. Change in injecting behaviour among people treated for hepatitis C virus: The role of intimate partnerships. J Viral Hepatitis. 2019;26(1):65\u201372.","journal-title":"J Viral Hepatitis"},{"key":"1452_CR28","doi-asserted-by":"publisher","first-page":"107620","DOI":"10.1016\/j.drugalcdep.2019.107620","volume":"205","author":"E Pike","year":"2019","unstructured":"Pike E, Tillson M, Webster JM, Staton M. A mixed-methods assessment of the impact of the opioid epidemic on first responder burnout. Drug Alcohol Depend. 2019;205:107620.","journal-title":"Drug Alcohol Depend"},{"key":"1452_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.drugpo.2018.11.008","volume":"74","author":"D Shearer","year":"2019","unstructured":"Shearer D, Fleming T, Boyd J, McNeil R. Naloxone distribution, trauma, and supporting community-based overdose responders. Int J Drug Policy. 2019;74:255.","journal-title":"Int J Drug Policy"},{"key":"1452_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.17269\/s41997-018-0044-7","volume":"109","author":"E Jozaghi","year":"2018","unstructured":"Jozaghi E, Maynard R, Dadakhah-Chimeh Z, Yake K, Blyth S. The synthetic opioid epidemic and the need for mental health support for first responders who intervene in overdose cases. Can J Public Health. 2018;109:231\u20132.","journal-title":"Can J Public Health"},{"key":"1452_CR31","unstructured":"Matheson C, Carver H, Parkes T, Daneshvar H, Schofield J, Dumbrell J, et al. Digital inclusion to prevent drug related deaths: scoping user needs. Drugs Res Network Scotland. 2022."},{"issue":"4","key":"1452_CR32","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/jrh.12737","volume":"39","author":"D Button","year":"2022","unstructured":"Button D, Levander XA, Cook RR, Miller WC, Salisbury-Afshar EM, Tsui JI, et al. Substance use disorder treatment and technology access among people who use drugs in rural areas of the United States: a cross-sectional survey. J Rural Health. 2022;39(4):772.","journal-title":"J Rural Health"},{"issue":"1","key":"1452_CR33","doi-asserted-by":"publisher","first-page":"e0227298","DOI":"10.1371\/journal.pone.0227298","volume":"15","author":"O Magwood","year":"2020","unstructured":"Magwood O, Salvalaggio G, Beder M, Kendall C, Kpade V, Daghmach W, et al. The effectiveness of substance use interventions for homeless and vulnerably housed persons: a systematic review of systematic reviews on supervised consumption facilities, managed alcohol programs, and pharmacological agents for opioid use disorder. PLoS ONE. 2020;15(1):e0227298.","journal-title":"PLoS ONE"},{"issue":"3","key":"1452_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/09687637.2021.1926429","volume":"29","author":"JA Miler","year":"2022","unstructured":"Miler JA, Foster R, Hnizdilova K, Murdoch H, Parkes T. \u2018It maybe doesn\u2019t seem much, but to me it\u2019s my kingdom\u2019: staff and client experiences of Housing First in Scotland. Drugs Education, Prev Policy. 2022;29(3):231\u201344.","journal-title":"Drugs Education, Prev Policy."},{"issue":"7","key":"1452_CR35","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/add.15336","volume":"116","author":"H Manhica","year":"2021","unstructured":"Manhica H, Straatmann VS, Lundin A, Agardh E, Danielsson AK. Association between poverty exposure during childhood and adolescence, and drug use disorders and drug\u2010related crimes later in life. Addiction. 2021;116(7):1747\u201356.","journal-title":"Addiction"},{"issue":"4","key":"1452_CR36","first-page":"320","volume":"48","author":"R P\u00e9rez-Figueroa","year":"2022","unstructured":"P\u00e9rez-Figueroa R, Obonyo D, Santoscoy S, Surratt H, Lekas H, Lewis C, et al. Housing instability, structural vulnerability, and non-fatal opioid overdoses among people who use heroin in Washington Heights. New York City Behav Med. 2022;48(4):320\u201330.","journal-title":"New York City Behav Med"},{"key":"1452_CR37","doi-asserted-by":"publisher","first-page":"103670","DOI":"10.1016\/j.drugpo.2022.103670","volume":"104","author":"GW Shorter","year":"2022","unstructured":"Shorter GW, Harris M, McAuley A, Trayner KM, Stevens A. The United Kingdom\u2019s first unsanctioned overdose prevention site; a proof-of-concept evaluation. Int J Drug Policy. 2022;104:103670.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1452_CR38","doi-asserted-by":"publisher","first-page":"e2142676-e","DOI":"10.1001\/jamanetworkopen.2021.42676","volume":"5","author":"DR Fine","year":"2022","unstructured":"Fine DR, Dickins KA, Adams LD, De LasNueces D, Weinstock K, Wright J, et al. Drug overdose mortality among people experiencing homelessness, 2003\u20132018. JAMA Netw Open. 2022;5(1):e2142676-e.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"1452_CR39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/(SICI)1097-4679(199704)53:3<215::AID-JCLP4>3.0.CO;2-Q","volume":"53","author":"DC Bell","year":"1997","unstructured":"Bell DC, Montoya ID, Atkinson JS. Therapeutic connection and client progress in drug abuse treatment. J Clin Psychol. 1997;53(3):215\u201324.","journal-title":"J Clin Psychol"},{"issue":"3","key":"1452_CR40","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1360-0443.2004.00935.x","volume":"100","author":"PS Meier","year":"2005","unstructured":"Meier PS, Barrowclough C, Donmall MC. The role of the therapeutic alliance in the treatment of substance misuse: a critical review of the literature. Addiction. 2005;100(3):304\u201316.","journal-title":"Addiction"},{"key":"1452_CR41","doi-asserted-by":"publisher","first-page":"209154","DOI":"10.1016\/j.josat.2023.209154","volume":"154","author":"S Blawatt","year":"2023","unstructured":"Blawatt S, Harrison S, Byres D, Foreman J, Amara S, Burdge W, et al. The mobilization of nurse-client therapeutic relationships in injectable opioid agonist treatment: autonomy, advocacy and action. JSubstance Use Addict Treat. 2023;154:209154.","journal-title":"J.Substance Use Addict Treat"},{"issue":"1","key":"1452_CR42","first-page":"12","volume":"1","author":"N Banazadeh","year":"2009","unstructured":"Banazadeh N, Kheradmand A, Abedi H. Opiate dependents\u2019 experiences of the therapeutic relationship in methadone centers; a qualitative study. Addict Health. 2009;1(1):12.","journal-title":"Addict Health"},{"issue":"2","key":"1452_CR43","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/add.13602","volume":"112","author":"A McAuley","year":"2017","unstructured":"McAuley A, Bouttell J, Barnsdale L, Mackay D, Lewsey J, Hunter C, et al. Evaluating the impact of a national naloxone programme on ambulance attendance at overdose incidents: a controlled time\u2013series analysis. Addiction. 2017;112(2):301\u20138.","journal-title":"Addiction"},{"key":"1452_CR44","unstructured":"Hillen P, Speakman E, Dougall N, Heyman I, Murray J, Jamieson M, et al. Naloxone in Police Scotland: Pilot Evaluation. 2022."},{"issue":"1","key":"1452_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12954-023-00750-9","volume":"20","author":"EM Speakman","year":"2023","unstructured":"Speakman EM, Hillen P, Heyman I, Murray J, Dougall N, Aston EV, et al. \u2018I\u2019m not going to leave someone to die\u2019: carriage of naloxone by police in Scotland within a public health framework: a qualitative study of acceptability and experiences. Harm Reduct J. 2023;20(1):20.","journal-title":"Harm Reduct J"},{"key":"1452_CR46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.drugalcdep.2015.12.018","volume":"159","author":"C Rowe","year":"2016","unstructured":"Rowe C, Santos G-M, Behar E, Coffin PO. Correlates of overdose risk perception among illicit opioid users. Drug Alcohol Depend. 2016;159:234\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"1452_CR47","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/aje\/kwr318","volume":"175","author":"JL Evans","year":"2012","unstructured":"Evans JL, Tsui JI, Hahn JA, Davidson PJ, Lum PJ, Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am J Epidemiol. 2012;175(4):302\u20138.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"1452_CR48","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.drugalcdep.2010.10.021","volume":"115","author":"S Darke","year":"2011","unstructured":"Darke S, Mills KL, Ross J, Teesson M. Rates and correlates of mortality amongst heroin users: findings from the Australian treatment outcome study (ATOS), 2001\u20132009. Drug Alcohol Depend. 2011;115(3):190\u20135.","journal-title":"Drug Alcohol Depend"},{"key":"1452_CR49","doi-asserted-by":"publisher","first-page":"794785","DOI":"10.3389\/fpsyt.2021.794785","volume":"12","author":"R Leach","year":"2022","unstructured":"Leach R, Carreiro S, Shaffer PM, Gaba A, Smelson D. Digital health interventions for mental health, substance use, and co-occurring disorders in the criminal justice population: a scoping review. Front Psychiatry. 2022;12:794785.","journal-title":"Front Psychiatry"},{"issue":"8","key":"1452_CR50","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.9873","volume":"20","author":"S Nesv\u00e5g","year":"2018","unstructured":"Nesv\u00e5g S, McKay JR. Feasibility and effects of digital interventions to support people in recovery from substance use disorders: systematic review. J Med Internet Res. 2018;20(8):e255.","journal-title":"J Med Internet Res"},{"key":"1452_CR51","doi-asserted-by":"publisher","first-page":"109138","DOI":"10.1016\/j.drugalcdep.2021.109138","volume":"229","author":"AM Roth","year":"2021","unstructured":"Roth AM, Tran NK, Cocchiaro B, Mitchell AK, Schwartz DG, Hensel DJ, et al. Wearable biosensors have the potential to monitor physiological changes associated with opioid overdose among people who use drugs: A proof-of-concept study in a real-world setting. Drug Alcohol Depend. 2021;229:109138.","journal-title":"Drug Alcohol Depend"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-026-01452-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01452-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01452-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:01:50Z","timestamp":1784080910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-026-01452-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1452"],"URL":"https:\/\/doi.org\/10.1186\/s12954-026-01452-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5535000\/v1","asserted-by":"object"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PneumoWave Limited donated the study equipment; however, the study is investigator initiated and the company has no control over the data. Kristina Hn\u00edzdilov\u00e1 is funded by an MRC iCASE studentship. Andrew Radley is in receipt of research grants from Camurus and Merck, Sharp and Dohme. The remaining authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"119"}}